Dendrimer‐Based Lipid Nanoparticles Deliver Therapeutic FAH mRNA to Normalize Liver Function and Extend Survival in a Mouse Model of Hepatorenal Tyrosinemia Type I-Reference-Cited by-同舟云学术

Dendrimer‐Based Lipid Nanoparticles Deliver Therapeutic FAH mRNA to Normalize Liver Function and Extend Survival in a Mouse Model of Hepatorenal Tyrosinemia Type I

Published:2018-10-25 Issue:52 Volume:30 Page:1805308
ISSN:0935-9648
Container-title:Advanced Materials
language:en
Short-container-title:Adv. Mater.

Author:

Cheng Qiang¹,Wei Tuo¹,Jia Yuemeng²,Farbiak Lukas¹,Zhou Kejin¹,Zhang Shuyuan²,Wei Yonglong²,Zhu Hao²,Siegwart Daniel J.¹^ORCID

Affiliation:

1. Simmons Comprehensive Cancer Center Department of Biochemistry University of Texas Southwestern Medical Center Dallas TX 75390 USA

2. Children's Research Institute Departments of Pediatrics and Internal Medicine The University of Texas Southwestern Medical Center Dallas TX 75390 USA

Funder

U.S. Department of Defense

American Cancer Society

Cancer Prevention and Research Institute of Texas

Welch Foundation

National Institutes of Health

Publisher

Wiley

Subject

Mechanical Engineering,Mechanics of Materials,General Materials Science

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/adma.201805308